Suppressed phospholamban levels diffferentiate irreversibly dysfunctional from hibernating myocardium in humans

Scandinavian Cardiovascular Journal

Volumn 39, Issue 1, 2005, Pages 55-59

  Wiggers, Henrik ^a   Nielsen, Torsten Toftegaard ^a   Vorum, Henrik ^b   Honoré, Bent ^b   Randsbæk, Flemming ^a   Kimose, Hans Henrik ^a   Paulsen, Peter Kildeberg ^a   Bøtker, Hans Erik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Contractility; Heart failure; Hibernation; Myocardial stunning; Phospholamban; SERCA2a

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); PHOSPHOLAMBAN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN TISSUE; IRREVERSIBLY DYSFUNCTIONAL MYOCARDIUM; MALE; MYOCARDIAL DISEASE; MYOCARDIAL HIBERNATION; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; SARCOPLASMIC RETICULUM;

ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CASE-CONTROL STUDIES; CORONARY ARTERY BYPASS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL STUNNING; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROGNOSIS; REFERENCE VALUES; SAMPLING STUDIES; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TISSUE CULTURE TECHNIQUES;

EID: 18644376594     PISSN: 14017431     EISSN: None     Source Type: Journal    
DOI: 10.1080/14017430510009005     Document Type: Article

References (26)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J. 1989;117:211-21.
2. Vanoverschelde JL, Wijns W, Depre C, Essamri B, Heyndrickx GR, Borgers M, Bol M, Melin JA. Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation. 1993;87(5):1513-23.
3. Elsasser A, Schlepper M, Klovekorn WP, Cai WJ, Zimmermann R, Muller KD, Strasser R, Kostin S, Gagel C, Munkel B, Schaper W, Schaper J. Hibernating myocardium: An incomplete adaptation to ischemia. Circulation. 1997;96(9):2920-31.
4. Schwarz ER, Schoendube FA, Kostin S, Schmiedtke N, Schulz G, Buell U, Messmer BJ, Morrison J, Hanrath P, vom Dahl J. Prolonged myocardial hibernation exacerbates cardiomyocyte degeneration and impairs recovery of function after revascularization. J Am Coll Cardiol. 1998;31(5):1018-26.
5. Atar D, Gao WD, Marban E. Alterations of excitation-contraction coupling in stunned myocardium and in failing myocardium. J Mol Cell Cardiol. 1995;27:783-91.
6. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. 1997;80:393-9.
7. Bito V, Heinzel FR, Weidemann F, Dommke C, van der Velden J, Verbeken E, Claus P, Bijnens B, De Scheerder J, Stienen GJ, Sutherland GR, Sipido KR. Cellular mechanisms of contractile dysfunction in hibernating myocardium. Circ Res. 2004;94(6):794-801.
8. +)-ATPase, phospholamban, and HSP-70 expression in chronic hibernating myocardium. Am J Physiol. 1999;277:H1418-28.
9. Deindl E, Neubauer E, Elsasser A, Zimmermann R, Schaper W. Reduced contractile function characteristic of hibernating human heart is not mediated by phospholamban. Ann N Y Acad Sci. 1998;16:270-2.
10. Lüss H, Schäfers M, Neumann J, Hammel D, Valhaus C, Baba HA, Janssen F, Scheld HH, Breithardt OA, Schober O. Biochemical mechanisms of hibernation and stunning in the human heart. Cardiovasc Res. 2002;56:411-21.
11. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res. 1998;37:279-89.
12. Vanoverschelde JJ, Depre C, Gerber BL, Borgers M, Wijns W, Robert A, Dion R, Melin JA. Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol. 2000;85:1432-9.
13. Wiggers H, Bottcher M, Egeblad H, Molgaard H, Nielsen TT, Botker HE. Impact of daily life myocardial ischemia in patients with chronic reversible and irreversible myocardial dysfunction. Am J Cardiol. 2002;89:22-8.
14. Wiggers H, Noreng M, Paulsen PP, Bottcher M, Egeblad H, Nielsen TT, Botker HE. Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans. J Am Coll Cardiol. 2001;1:100-8.
15. Wiggers H, Nielsen TT, Bøttcher M, Egeblad H, Bøtker HE. Positron emission tomography and low-dose dobutamine echocardiography in the prediction of post-revascularization improvement in left ventricular function and exercise parameters. Am Heart J. 2000;140:928-36.
16. Luo W, Grupp IL, Harrer S, Ponniah G, Grupp JJ, Duffy T, Doetschmann T, Kranias EG. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation. Circ Res. 1994;75:401-9.
17. Suzuki T, Wang WH. Stimulation of bovine cardiac sarcoplasmatic reticulum Ca2+ pump and blocking of phospholamban phosphorylation and dephosphorylation by a monoclonal antibody. J Biol Chem. 1986;261:7018-23.
18. Heusch G, Rose J, Skyschally A, Post H, Schulz R. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potentiation and intracoronary calcium. Circulation. 1996;93:1556-66.
19. Fallavollita JA, Malm BJ, Canty JM, Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res. 2003;92:48-55.
20. Elsasser A, Muller KD, Skwara W, Bode C, Kubler W, Vogt AM. Severe energy deprivation of human hibernating myocardium as possible common pathomechanism of contractile dysfunction, structural degeneration and cell death. J Am Coll Cardiol. 2002;39:1189-98.
21. Bax JJ, Schinkel AFL, Boersma E, Rizzello V, Elhendy A, Maat A, Roelandt JR, van der Wan EE, Poldermans D. Early versus delayed revascularization in patients with ischemic cardiomyopathy and sustained viability: Impact on outcome. Circulation. 2003;108(Suppl II):II39-42.
22. Cross HR, Kranias EG, Murphy E, Steenbergen C. Ablation of PLB exacerbates ischemic injury to a lesser extent in female than male mice: Protective role of NO. Am J Physiol Heart Circ Physiol. 2003;284:H683-90.
23. Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation. 1995;92:15-23.
24. + uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation. 1995;92:3220-8.
25. Fallavollita J, Lim H, Canty JM, Jr. Myocyte apoptosis and reduced SR gene expression precede the transition from chronically stunned to hibernating myocardium. J Mol Cell Cardiol. 2001;33:1937-41.
26. Haas F, Augustin N, Holper K, Wottke M, Haehnel C, Nekolla S, Meisner H, Lange R, Schwaiger M. Time course and extent of improvement of dysfunctioning myocardium in patients with coronary artery disease and severely depressed left ventricular function after revascularization: Correlation with positron emission tomographic findings. J Am Coll Cardiol. 2000;36:1927-34.